Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance

BMC Neurology - 2013
Ruth Ann Marrie1,2,3, John D. Fisk4, Bo Yu3, Stella Leung3, Lawrence Elliott3, Patrícia Caetano3, Sharon Warren5, Charity Evans6, Christina Wolfson7,8, Lawrence W. Svenson9,10,11, Helen Tremlett12, James Blanchard3, Scott B. Patten9
1Department of Medicine (Neurology), University of British Columbia, Vancouver, Canada
2Department of Internal Medicine, University of Manitoba, Winnipeg, Canada
3Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada
4Health Sciences Centre, Winnipeg, Canada
5Departments of Psychiatry and Medicine, Dalhousie University, Halifax, Canada
6Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Canada
7Department of Epidemiology and Biostatistics and Occupational Health, McGill University, Montreal, Canada
8College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
9Research Institute of the McGill University Health Centre, Montreal, Canada
10Department of Community Health Sciences, University of Calgary, Calgary, Canada
11School of Public Health, University of Alberta, Edmonton, Canada
12Surveillance and Assessment, Alberta Health, Edmonton, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Goldman Consensus Group: The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler. 2005, 11: 328-337.

Korostil M, Feinstein A: Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler. 2007, 13: 67-72. 10.1177/1352458506071161.

Rodgers J, Bland R: Psychiatric manifestations of multiple sclerosis: a review. Can J Psychiatry. 1996, 41: 441-445.

Patten SB, Svenson LW, Metz LM: Psychotic disorders in MS: Population-based evidence of an association. Neurology. 2005, 65 (7): 1123-1125. 10.1212/01.wnl.0000178998.95293.29.

Marrie RA, Horwitz R, Cutter G, Tyry T: Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012, 125 (3): 180-186. 10.1111/j.1600-0404.2011.01526.x.

Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA: Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997, 54: 531-533. 10.1001/archneur.1997.00550170015009.

Patten S: Integrating data from clinical and administrative databases in pharmacoepidemiological research. Can J Clin Pharmacol. 1998, 5 (2): 92-97.

Asche CV, Singer ME, Jhaveri M, Chung H, Miller A: All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J Manag Care Pharm. 2010, 16 (9): 703-712.

Haro JM, Arbabzadeh-Bouchez S, Brugha TS, De Girolamo G, Guyer ME, Jin R, Lepine JP, Mazzi F, Reneses B, Vilagut G: Concordance of the composite international diagnostic interview version 3.0 (CIDI 3.0) With standardized clinical assessments in the WHO world mental health surveys. Int J Methods Psychiatr Res. 2006, 15 (4): 167-180. 10.1002/mpr.196.

Tricco AC, Pham B, Rawson NSB: Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. J Clin Epidemiol. 2008, 61 (2): 192-197. 10.1016/j.jclinepi.2007.03.009. e112

Martens P, Fransoo R, McKeen N, Burland E, Jebamani L, Burchill C, Coster CD, Ekuma O, Prior H, Chateau D: Patterns of regional mental illness disorder diagnoses and service use in Manitoba: a population-based study. 2004, Winnipeg: Manitoba Centre for Health Policy, University of Manitoba

Kisely S, Lin E, Gilbert C, Smith M, Campbell L-A, Vasiliadis H-M: Use of administrative data for the surveillance of mood and anxiety disorders. Aust N Z J Psychiatry. 2009, 43 (12): 1118-1125. 10.3109/00048670903279838.

Branch HIM: Population report. 2008, Winnipeg, Manitoba: Manitoba Health and Healthy Living

Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L: The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 2010, 74 (6): 465-471. 10.1212/WNL.0b013e3181cf6ec0.

Horton M, Rudick RA, Hara-Cleaver C, Marrie RA: Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010, 35 (2): 83-90. 10.1159/000311013.

Marrie R, Yu B, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten S, Svenson L, Tremlett H: Rising prevalence of vascular comorbidities in MS: validation of administrative definitions for diabetes, hypertension, hyperlipidemia. Multiple Sclerosis Journal. 2012, 10.1177/1352458512437814.

Samkoff LM, Goodman AD: Symptomatic management in multiple sclerosis. Neurol Clin. 2011, 29 (2): 449-463. 10.1016/j.ncl.2011.01.008.

Anatomic therapeutic chemical classification system. http://www.whocc.no/atc/structure_and_principles/ ,

Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33: 159-174. 10.2307/2529310.

Sim J, Wright CC: The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005, 85: 257-268.

Kleinbaum D, Kupper L, Morgenstern H: Information bias. Epidemiologic research: principles and quantitative methods. 1982, New York: Van Nostrand Reinhold, 220-241.

Dahl O-P, Stordal E, Lydersen S, Midgard R: Anxiety and depression in multiple sclerosis. A comparative population-based study in nord-trondelag county, norway. Mult Scler. 2009, 15 (12): 1495-1501. 10.1177/1352458509351542.

Wood B, van der Mei I, Ponsonby A-L, Pittas F, Quinn S, Dwyer T, Lucas R, Taylor B: Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Multiple Sclerosis Journal. 2012, 10.1177/1352458512450351. Epub ahead of print

Edwards LJ, Constantinescu CS: A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler. 2004, 10: 575-581. 10.1191/1352458504ms1087oa.

Fisk J, Morehouse SA, Brown MG, Skedgel C, Murray TJ: Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci. 1998, 25: 230-235.

Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z: Mood disorder and multiple sclerosis. Arch Neurol. 1987, 44: 376-378. 10.1001/archneur.1987.00520160018007.

Jacobs LD, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, Gottesman MH, Granger CV, Greenberg SJ, Herbert J: A profile of multiple sclerosis: the New york state multiple sclerosis consortium. Mult Scler. 1999, 5 (5): 369-376.

Marrie RA, Horwitz RI, Cutter G, Tyry T, Campagnolo D, Vollmer T: The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and under-treated. Mult Scler. 2009, 15 (3): 385-392. 10.1177/1352458508099477.

West SL, Richter A, Melfi CA, McNutt M, Nennstiel ME, Mauskopf JA: Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J Clin Epidemiol. 2000, 53 (8): 823-831. 10.1016/S0895-4356(99)00237-1.

Unützer J, Simon G, Pabiniak C, Bond K, Katon W: The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. Gen Hosp Psychiatry. 2000, 22 (1): 1-10. 10.1016/S0163-8343(99)00057-2.

Rawson NS, Malcolm E, D'Arcy C: Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol. 1997, 32 (4): 191-199. 10.1007/BF00788238.

Kashner TM: Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care. 1998, 36 (9): 1324-1336. 10.1097/00005650-199809000-00005.

Lurie N, Popkin M, Dysken M, Moscovice I, Finch M: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry. 1992, 43 (1): 69-71.

Elixhauser A, Steiner C, Harris DR, Coffey RM: Comorbidity measures for use with administrative data. Med Care. 1998, 36: 8-27. 10.1097/00005650-199801000-00004.

Kang J-H, Chen Y-H, Lin H-C: Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J Neurol. 2010, 17 (9): 1215-1219. 10.1111/j.1468-1331.2010.02971.x.

Thông tin
Thông tin xuất bản

BMC Neurology

Thông tin tác giả